Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. (PubMed, Brain Behav) - Jun 18, 2026 - "ROZ 10 mg/kg ranked best for MG-ADL. BAT 680 mg significantly reduced QMG and ranked best. BAT 340 mg had the highest probability of reducing the MGC score. ECU significantly decreased MG-QoL 15r and ranked best. BEL 10 mg/kg had the highest likelihood of reducing adverse events."
Clinical • Journal • Retrospective data • Review • CNS Disorders • Immunology • Myasthenia Gravis
|
|
Adam A Dmytriw; Minahil Iqbal; Muhammad Hassan Waseem; Pawan Kumar Thada; Saniya Ishtiaq; Zain Ul Abideen
|